Yiling Pharmaceutical Inc.   Report issue

Founded: Shijiazhuang China (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2014
NCT02035644
First Marketed Drug
2007
amlodipine (norvasc)
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

BEIJING YILING | Conjupro Biotherapeutics | Conjupro Biotherapeutics, Inc. | Conupro Biotehrapeutics, and CSPC | CSPC Ouyi Pharmaceutical Co., Ltd. | Shijiazhuang Yiling Pharmaceutical Co. Ltd | Shijiazhuang Yiling Pharmaceutical company, LTD | YILING | Yiling Pharmaceutical Inc. | YILING PHARM LTD